Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors

mctpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This paper outlines the protocol for a randomized controlled trial evaluating ConquerFear-HK, a metacognition-based intervention adapted for Chinese cancer survivors with fear of cancer recurrence. The study compares this manualized treatment against a standard survivorship care control group across six sessions delivered by trained therapists. It details the recruitment of 174 participants and specifies primary and secondary outcome measures, including fear of recurrence, metacognition, and quality of life, assessed at baseline and follow-up intervals.

ID
b4d9534fcc404c65
Source org
PubMed Central
Author
Not recorded
Published
Not recorded
OA status
Not recorded
DOI
10.1136/bmjopen-2022-065075
PMID
Not recorded
PMCID
PMC9872480
Citations
Not recorded

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:b4d9534fcc404c65,
  title = {Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors},
  journal = {PubMed Central},
  doi = {10.1136/bmjopen-2022-065075},
  url = {https://doi.org/10.1136/bmjopen-2022-065075}
}

RIS

TY  - JOUR
TI  - Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors
PB  - PubMed Central
DO  - 10.1136/bmjopen-2022-065075
UR  - https://doi.org/10.1136/bmjopen-2022-065075
ER  -

APA

Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors. (n.d.). PubMed Central. https://doi.org/10.1136/bmjopen-2022-065075

Related entries

More like this